Testosterone replacement therapy use has been increasing; however, a gap exists in patients' understanding of this therapy and its associated risks, and available online resources might not be bridging this gap. Action should be taken to provide patients with accessible credible information.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rao, P. et al. Trends in testosterone replacement therapy use from 2003 to 2013 among reproductive-age men in the United States. J. Urol. 197, 1121–1126 (2017).
Bhasin, S. et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 95, 2536–2559 (2010).
Araujo, A. et al. Prevalence of symptomatic androgen deficiency in men. J. Clin. Endocrinol. Metab. 92, 4241–4247 (2007).
Gilbert, K., Cimmino, C. B., Beebe, L. C. & Mehta, A. Gaps in patient knowledge about risks and benefits of testosterone replacement therapy. Urology http://dx.doi.org/10.1016/j.urology.2016.12.066 (2017).
Layton, J. B., Kim, Y., Alexander, G. C. & Emery, S. L. Association between direct-to-consumer advertising and testosterone testing and initiation in the United States, 2009–2013. JAMA 317, 1159–1166 (2017).
McBride, J. A., Carson, C. C. & Coward, R. M. Readability, credibility and quality of patient information for hypogonadism and testosterone replacement therapy on the internet. Int. J. Impot. Res. http://dx.doi.org/10.1038/ijir.2017.4 (2017).
Weiss, B. Health literacy and patient safety. Help patients understand: manual for clinicians. American Medical Association http://med.fsu.edu/userFiles/file/ahec_health_clinicians_manual.pdf (2007).
The Joint Commission. “What did the doctor say?” Improving health literacy to protect patient safety. Joint Commission http://www.jointcommission.org/assets/1/18/improving_health_literacy.pdf (2007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J.M.D. declares contract grant support from Blue Cross Blue Shield of Michigan for his roles with the Michigan Value Collaborative and the Michigan Urologic Surgery Improvement Collaborative. In addition, he owns personal stock in Lipocine Inc. which develops a testosterone product. Y.A.Y. declares no competing interests.
Rights and permissions
About this article
Cite this article
Yi, Y., Dupree, J. Testosterone replacement therapy and the knowledge gap. Nat Rev Urol 14, 332–333 (2017). https://doi.org/10.1038/nrurol.2017.63
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2017.63